Arcturus Therapeutics Files 8-K on Financials
Ticker: ARCT · Form: 8-K · Filed: May 12, 2025 · CIK: 1768224
| Field | Detail |
|---|---|
| Company | Arcturus Therapeutics Holdings Inc. (ARCT) |
| Form Type | 8-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: ARCT
TL;DR
ARCT filed an 8-K detailing financial results and exhibits.
AI Summary
Arcturus Therapeutics Holdings Inc. filed an 8-K on May 12, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing provides updated information regarding the company's financial status and operational performance.
Why It Matters
This filing provides crucial updates on Arcturus Therapeutics' financial health and operational performance, which are key factors for investors to consider.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Arcturus Therapeutics Holdings Inc. (company) — Registrant
- May 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 10628 Science Center Drive, Suite 250, San Diego, California 92121 (address) — Principal executive offices
- (858) 900-2660 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K reports on Arcturus Therapeutics Holdings Inc.'s results of operations and financial condition, along with financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 12, 2025.
What is the principal executive office address for Arcturus Therapeutics Holdings Inc.?
The principal executive office address is 10628 Science Center Drive, Suite 250, San Diego, California 92121.
In which state was Arcturus Therapeutics Holdings Inc. incorporated?
Arcturus Therapeutics Holdings Inc. was incorporated in Delaware.
What is the telephone number for Arcturus Therapeutics Holdings Inc.?
The telephone number for Arcturus Therapeutics Holdings Inc. is (858) 900-2660.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding Arcturus Therapeutics Holdings Inc. (ARCT).